Manning Martha E

Avg. Two Year Performance

29% Avg. Purchase Return
14% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(3%)(10%)4%(28%)29%
Purchase Success Rate1 of 20 of 22 of 20 of 21 of 2
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 10 of 10 of 10 of 10 of 1
Drugs » Drug Manufacturers - Other

Sr.VP, General Counsel & Sec.:

Holdings: 11.46K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

General Counsel:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

SVP, GEN. COUNSEL & CORP. SEC.:

Holdings: 60.26K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--